Effects of levetiracetam on the production of nitric oxide--an in vivo study.
Dagonnier
Marie
M
Laute
Marie-Aline
MA
Pandolfo
Massimo
M
Manto
Mario
M
D000704:Analysis of Variance; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002531:Cerebellum / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D000077287:Levetiracetam; D008297:Male; D017551:Microdialysis / Q000379:methods; D016202:N-Methylaspartate / Q000494:pharmacology; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D010889:Piracetam / Q000031:analogs & derivatives* / Q000494:pharmacology*; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D000927:Anticonvulsants; D004791:Enzyme Inhibitors; D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D011810:Quinoxalines; D009569:Nitric Oxide; D000077287:Levetiracetam; C056723:FG 9041; D016202:N-Methylaspartate; D019331:NG-Nitroarginine Methyl Ester; D010889:Piracetam
Neurosci Res. 1997 Jun;28(2):93-102
9220466
Brain Res Mol Brain Res. 2001 Apr 18;89(1-2):111-8
11311981
Eur J Neurosci. 1996 Dec;8(12):2619-34
8996812
Neuroscience. 1992 Aug;49(4):903-11
1359457
Eur J Neurosci. 1990 Feb;2(2):177-180
12106061
J Cell Biol. 2001 Jul 23;154(2):355-68
11470824
Eur J Neurosci. 2003 Aug;18(4):869-78
12925012
Epileptic Disord. 2003 May;5 Suppl 1:S9-16
12915336
Prog Brain Res. 1998;118:269-80
9932448
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9861-6
15210974
Brain Res. 2003 Jun 27;976(2):227-33
12763257
Neuroscience. 2000;100(3):651-61
11098127
Neurochem Int. 2003 Jun;42(7):525-33
12590934